Navigation Links
Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders
Date:5/13/2008

- Shareholders Ratify Both Proposals -

LAKE FOREST, Ill., May 13 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today held its 2008 Annual Meeting of Shareholders in Wilmington, Del. The agenda included votes on two proposals and a brief update on the company's progress and strategy.

"Our 2007 results point to the success of our strategies of investing for growth, and improving operating margins and cash flow," said Christopher B. Begley, chairman and chief executive officer, Hospira. "It's through our disciplined focus on executing these strategies that Hospira has become the growing, profitable company it is today and is positioned for continued success going forward."

During the annual meeting, shareholders:

-- elected the following directors for three-year terms expiring in 2011:

Irving W. Bailey, II, Ronald A. Matricaria and

Jacque J. Sokolov, M.D.; and

-- ratified the appointment of Deloitte & Touche LLP as Hospira's auditors

for 2008.

A full description of the above matters was included in Hospira's proxy statement related to the meeting. The proxy statement is available on Hospira's Web site at http://www.hospirainvestor.com, as are Begley's remarks made at today's meeting.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.
Private Securities Litigation Reform Act of 1995 -- A Caution Concerning

Forward-Looking Statements This press release contains statements that may be construed as forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks, uncertainties and factors discussed under the headings "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Hospira's latest Annual Report on Form 10-K and the subsequent Form 10-Q, filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
2. Hospira Acquires Sculptor
3. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
4. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
5. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
6. Hospira Launches Generic Irinotecan Injection
7. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
8. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
9. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
10. Hospira Reports Third-Quarter 2007 Results
11. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: